Short answer · Medically reviewed summary · Last updated: 2026-04-07
Small Fiber Neuropathy (SFN) is a condition characterized by damage to the peripheral nerve fibers that transmit pain, temperature sensations, and regulate autonomic functions. Unlike large-fiber neuropathies, Small Fiber Neuropathy primarily impacts the thin, unmyelinated nerve endings in the skin and organs, often leading to debilitating chronic pain and autonomic instability despite normal results on standard nerve conduction studies. What exactly is Small Fiber Neuropathy and how does it affect the body? Small Fiber Neuropathy is a sensory and autonomic disorder.
2 people with Small Fiber Neuropathy have shared their first-person experience on this question at DiseaseMaps.
Small Fiber Neuropathy (SFN) is a condition characterized by damage to the peripheral nerve fibers that transmit pain, temperature sensations, and regulate autonomic functions. Unlike large-fiber neuropathies, Small Fiber Neuropathy primarily impacts the thin, unmyelinated nerve endings in the skin and organs, often leading to debilitating chronic pain and autonomic instability despite normal results on standard nerve conduction studies.
Small Fiber Neuropathy is a sensory and autonomic disorder. While large nerve fibers control muscle movement and deep sensation, small nerve fibers—known as A-delta and C-fibers—are responsible for detecting thermal changes and pain, as well as managing involuntary body functions like heart rate, digestion, and sweating. When Small Fiber Neuropathy occurs, these delicate fibers are damaged or lost. This often manifests as burning or tingling sensations in the extremities, but because the autonomic nervous system is also involved, patients may experience heart palpitations, lightheadedness upon standing, or gastrointestinal issues. At DiseaseMaps.org, 209 members have shared their experiences, highlighting the diverse and systemic nature of these symptoms.
Determining the exact prevalence of Small Fiber Neuropathy is challenging because it is often underdiagnosed or misdiagnosed as other conditions. Studies suggest an incidence rate of approximately 13 per 100,000 individuals, though this is likely an underestimate. Small Fiber Neuropathy can affect individuals of any age, though it is most commonly diagnosed in adults between the ages of 40 and 60. There is no significant gender bias, and it occurs globally across all ethnic groups. Because it can be secondary to other conditions, many patients are diagnosed only after investigating underlying systemic issues like diabetes or autoimmune disorders.
Clinicians generally categorize Small Fiber Neuropathy based on the underlying cause, as this directs the treatment approach. The disease is classified into three main groups:
The most critical distinction is that Small Fiber Neuropathy does not show up on traditional electromyography (EMG) or nerve conduction studies (NCS), which only measure large, myelinated fibers. This often leads to "normal" clinical test results, leaving patients feeling dismissed. To differentiate Small Fiber Neuropathy, specialists rely on specialized testing, such as a skin punch biopsy to count intraepidermal nerve fiber density (IENFD) or quantitative sudomotor axon reflex testing (QSART) to evaluate autonomic function.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.